A 50-year-old woman in Alberta, Canada, died of coagulation disorders after Astrazeneca's Covid-19 vaccination.

Dr. Dena Hinshaw, the head of the Alberta Provincial Health Authority of Canada, on May 4, said a 50-year-old woman died of the coagulation after Astrazeneca's Covid-19 vaccination.

The Alberta government two weeks ago announced a 60-year-old man who appeared blood clotting after Astrazeneca's Vaccine Covid-19, but was recovering.

"It is important to remember that the risk of death or serious consequences of Covid-19 is still much higher than the risk of complications after Astrazeneca vaccination," Dr. Hinshaw said.

Medical staff holding Astrazeneca's Vaccine Covid-19 at a vaccination facility in Kuala Lumpur, Malaysia, on 5/5.

Leaders of Alberta Provincial Health Agency said Guy muscles appeared with symptoms of clotting after vaccination globally only 1 / 100,000-1 / 250,000 injections.

According to data from real-time Worldometers, Canada recorded more than 1.2 million cases of NCOV and more than 24,000 deaths.

Many countries around the world currently apply different policies with Astrazeneca vaccine.

British Pharmaceutical and Health Care Management Agency (MHRA) on June 5 said that the copperctic complications after Astrazeneca vaccination occurred in women more than men, but this "does not occur in all groups

MHRA in the latest weekly documentation also added the proportion of cases of low blood clotting and platelet complications after Astrazeneca vaccine is 10.5 / 1,000,000 doses, added compared to 9.3 / 1,000.